Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stein

Showing results (551-560 of 576) with videos related to

Pageof 58
Sort By:
Artificial Organs|August 27, 1999
Chronic survival of calves implanted with the DeBakey ventricular assist deviceT W Fossum, D Morley, R Benkowski, et al.
The British Journal of Dermatology|July 25, 2023
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)Linda F Stein Gold, Jerry Bagel, Stephen K Tyring, et al.
Applied Developmental Science|January 27, 2023
Conducting Virtual Assessments in Developmental Research: COVID-19 Restrictions as a Case ExampleG Anne Bogat, Kristyn Wong, Maria Muzik, et al.
American Journal of Human Genetics|October 30, 2004
A 77-kilobase region of chromosome 6p22.2 is associated with dyslexia in families from the United Kingdom and from the United StatesClyde Francks, Silvia Paracchini, Shelley D Smith, et al.
American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Journal of the American Academy of Dermatology|May 16, 2025
Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind StudyLawrence F Eichenfield, Linda F Stein Gold, Eric L Simpson, et al.
Human Molecular Genetics|April 8, 2006
The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migrationSilvia Paracchini, Ankur Thomas, Sandra Castro, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2022
Detection of human Mastadenovirus C in wild guinea pigs (Cavia aperea aperea) fecesAlexandre Sita, Gabriela E Birlem, Paula R de Almeida, et al.
Nature Genetics|December 18, 2001
Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexiaSimon E Fisher, Clyde Francks, Angela J Marlow, et al.
JAMA Dermatology|March 9, 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical TrialsEric L Simpson, Kim A Papp, Andrew Blauvelt, et al.
Pageof 58

Showing results (551-560 of 576) with videos related to

Sort By:
Pageof 58
Artificial Organs|August 27, 1999
Chronic survival of calves implanted with the DeBakey ventricular assist deviceT W Fossum, D Morley, R Benkowski, et al.
The British Journal of Dermatology|July 25, 2023
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)Linda F Stein Gold, Jerry Bagel, Stephen K Tyring, et al.
Applied Developmental Science|January 27, 2023
Conducting Virtual Assessments in Developmental Research: COVID-19 Restrictions as a Case ExampleG Anne Bogat, Kristyn Wong, Maria Muzik, et al.
American Journal of Human Genetics|October 30, 2004
A 77-kilobase region of chromosome 6p22.2 is associated with dyslexia in families from the United Kingdom and from the United StatesClyde Francks, Silvia Paracchini, Shelley D Smith, et al.
American Journal of Clinical Dermatology|March 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller, et al.
Journal of the American Academy of Dermatology|May 16, 2025
Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind StudyLawrence F Eichenfield, Linda F Stein Gold, Eric L Simpson, et al.
Human Molecular Genetics|April 8, 2006
The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migrationSilvia Paracchini, Ankur Thomas, Sandra Castro, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2022
Detection of human Mastadenovirus C in wild guinea pigs (Cavia aperea aperea) fecesAlexandre Sita, Gabriela E Birlem, Paula R de Almeida, et al.
Nature Genetics|December 18, 2001
Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexiaSimon E Fisher, Clyde Francks, Angela J Marlow, et al.
JAMA Dermatology|March 9, 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical TrialsEric L Simpson, Kim A Papp, Andrew Blauvelt, et al.
Pageof 58